Free Trial

Cerevel Therapeutics (CERE) Insider Trading & Ownership

$40.31
-0.74 (-1.80%)
(As of 07/12/2024 ET)

Cerevel Therapeutics (NASDAQ:CERE) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
5.10%
Number Of
Insiders Buying
(Last 12 Months)
4
Amount Of
Insider Buying
(Last 12 Months)
$147.51 M
Number Of
Insiders Selling
(Last 12 Months)
7
Amount Of
Insider Selling
(Last 12 Months)
$12.54 M
Get CERE Insider Trade Alerts

Want to know when executives and insiders are buying or selling Cerevel Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

CERE Insider Buying and Selling by Quarter

Cerevel Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/1/2024N Anthony ColesDirectorSell25,000$41.18$1,029,500.00  
5/10/2024N Anthony ColesDirectorSell50,000$42.10$2,105,000.00  
3/4/2024N Anthony ColesDirectorSell50,000$41.01$2,050,500.00  
2/29/2024N Anthony ColesDirectorSell50,000$41.16$2,058,000.00  
2/7/2024John RengerInsiderSell2,161$41.54$89,767.94  
2/7/2024N Anthony ColesDirectorSell2,506$41.54$104,099.24  
12/26/2023Ramiro SanchezInsiderSell10,000$42.47$424,700.00  
12/22/2023Kenneth DipietroInsiderSell8,000$41.45$331,600.00  
12/20/2023Mark BodenraderInsiderSell7,889$41.42$326,762.38  
12/20/2023Susan AltschullerCFOSell13,808$41.42$571,927.36  
12/7/2023Scott AkamineInsiderSell10,000$41.37$413,700.00  
12/5/2023Scott AkamineInsiderSell7,500$35.00$262,500.00  
11/8/2023N Anthony ColesDirectorSell100$25.16$2,516.00  
11/3/2023N Anthony ColesDirectorSell61,401$25.43$1,561,427.43  
10/16/2023Bain Capital Investors LlcMajor ShareholderBuy5,480,052$22.81$124,999,986.12  
10/16/2023Perceptive Advisors LlcDirectorBuy876,808$22.81$19,999,990.48  
9/7/2023N Anthony ColesDirectorSell50,000$24.07$1,203,500.00  
8/4/2023Paul D BurgessInsiderBuy21,880$22.93$501,708.40  
8/3/2023Ronald C Renaud JrCEOBuy83,857$23.96$2,009,213.72  
(Data available from 1/1/2013 forward)

CERE Insider Trading Activity - Frequently Asked Questions

Who is on Cerevel Therapeutics's Insider Roster?

The list of insiders at Cerevel Therapeutics includes Abraham Ceesay, Bain Capital Investors Llc, Deval L. Patrick, John Renger, Kenneth Dipietro, Marijn E Dekkers, Mark Bodenrader, N Anthony Coles, Paul D Burgess, Perceptive Advisors Llc, Ramiro Sanchez, Ronald C Renaud Jr, Scott Akamine, and Susan Altschuller. Learn more on insiders at CERE.

What percentage of Cerevel Therapeutics stock is owned by insiders?

5.10% of Cerevel Therapeutics stock is owned by insiders. Learn more on CERE's insider holdings.

Which Cerevel Therapeutics insiders have been buying company stock?

The following insiders have purchased CERE shares in the last 24 months: Bain Capital Investors Llc ($124,999,986.12), Paul D Burgess ($501,708.40), Perceptive Advisors Llc ($69,874,990.48), and Ronald C Renaud Jr ($2,009,213.72).

How much insider buying is happening at Cerevel Therapeutics?

Insiders have purchased a total of 7,887,597 CERE shares in the last 24 months for a total of $197,385,898.72 bought.

Which Cerevel Therapeutics insiders have been selling company stock?

The following insiders have sold CERE shares in the last 24 months: Abraham Ceesay ($936,487.50), Deval L. Patrick ($1,468,359.90), John Renger ($3,817,267.94), Kenneth Dipietro ($331,600.00), Marijn E Dekkers ($6,886,000.00), Mark Bodenrader ($389,202.63), N Anthony Coles ($20,641,112.67), Ramiro Sanchez ($424,700.00), Scott Akamine ($676,200.00), and Susan Altschuller ($571,927.36).

How much insider selling is happening at Cerevel Therapeutics?

Insiders have sold a total of 1,084,780 Cerevel Therapeutics shares in the last 24 months for a total of $36,142,858.00 sold.


This page (NASDAQ:CERE) was last updated on 7/14/2024 by MarketBeat.com Staff

From Our Partners